Thornton Law Firm
  • Home
  • About
  • Cases We Handle
    • Birth Defects
    • Drugs and Medical Devices Litigation
    • False Claims Act and Fraud
    • Mesothelioma and Asbestos
    • Personal Injury
    • PFAS Chemical Exposure
    • Silicosis
    • Toxic Torts
  • Attorneys
    • Our Partner Attorneys
      • Michael P. Thornton
      • David J. McMorris
      • David C. Strouss
      • Andrew S. Wainwright
      • Michael A. Lesser
      • Marilyn T. McGoldrick
      • Brad J. Mitchell
      • Andrea Marino Landry
      • Evan R. Hoffman
      • Leah McMorris
      • Brian J. Freer
      • Leslie-Anne Taylor
      • Christian F. Uehlein
    • Our Associate Attorneys
      • Ginger A. Gibbs
      • Malissa A. Riehl
      • Dhespina Poreci
      • Justin Carter
    • Of Counsel Attorneys
      • John T. Barrett
      • David Bricker
      • Patricia M. Flannery
    • Asbestos Staff
      • Allison Elder
      • Lisa Peterson
      • Joseph D. Souza
      • Chris Corradetti
      • David A. Talanian
  • Significant Cases
  • Blog
  • Careers
  • Contact
  • Call: (888) 491-9726
Select Page
FDA: Canagliflozin (Invokana, Invokamet) Must Add Amputation Risk Warning

FDA: Canagliflozin (Invokana, Invokamet) Must Add Amputation Risk Warning

by Marilyn McGoldrick, Esq. | May 16, 2017 | Uncategorized

Call 888-341-1405 for a free consultation with a recognized leader in personal injury and defective drug litigation. You can also contact us online to discuss the details of your case. By: Marilyn McGoldrick, Esq. UPDATE: The U.S. Food and Drug Administration (FDA)...
FDA: Canagliflozin (Invokana, Invokamet) Must Add Amputation Risk Warning

Invokana Cases Consolidated in MDL

by Marilyn McGoldrick, Esq. | Jan 3, 2017 | Uncategorized

Call 888-341-1405 for a free consultation with a recognized leader in personal injury and pharmaceutical drug litigation. You can also contact us online to discuss the details of your case. By: Marilyn McGoldrick, Esq. The Judicial Panel for Multidistrict...
FDA: Canagliflozin (Invokana, Invokamet) Must Add Amputation Risk Warning

FDA Warns Invokana May Lead To Ketoacidosis

by Marilyn McGoldrick, Esq. | Aug 19, 2015 | Uncategorized

By: Marilyn McGoldrick, Esq. The Food and Drug Administration recently issued a Drug Safety Communication warning doctors and patients that taking the new class of diabetes drugs known as SGLT2 inhibitors — including Invokana — may lead to high levels of blood acids...
Copyright © 2024 Thornton Law Firm. All rights reserved.

Tenlaw uses cookies to provide security and better understand how our website is used. By using this website, you agree with the use of cookies. For more information see our Cookie Notice. By clicking Accept, you agree to our privacy policy and use of these cookies.

Read Our Privacy Policy

Thornton Law Firm
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.